Search Results - "GAGE, J. W"

Comparative therapeutic efficacy of clinafloxacin in a pneumococcal meningitis mouse model by Shapiro, Martin A., Donovan, Kurt D., Gage, Jeffrey W.

“…The therapeutic efficacy of clinafloxacin, a fluoroquinolone in clinical trials, was compared with that of ciprofloxacin and ceftriaxone in a novel…”
Get full text

Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position by RENAU, T. E, GAGE, J. W, REYNOLDS, R. C, DEVER, J. A, ROLAND, G. E, JOANNIDES, E. T, SHAPIRO, M. A, SANCHEZ, J. P, GRACHECK, S. J, DOMAGALA, J. M, JACOBS, M. R

“…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
Get full text

Structure−Activity Relationships of the Quinolone Antibacterials against Mycobacteria:  Effect of Structural Changes at N-1 and C-7 by Renau, Thomas E, Sanchez, Joseph P, Gage, Jeffrey W, Dever, Julie A, Shapiro, Martin A, Gracheck, Stephen J, Domagala, John M

“…The re-emergence of tuberculosis infections which are resistant to conventional drug therapy has demonstrated the need for alternative chemotherapy against…”
Get full text

In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin by COHEN, M. A, HUBAND, M. D, GAGE, J. W, YODER, S. L, ROLAND, G. E, GRACHECK, S. J

“…Clinafloxacin and trovafloxacin are two new fluoroquinolones for which few comparative data are available. When MICs of ciprofloxacin against Gram-positive and…”
Get full text

Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies by COHEN, M. A, HUBAND, M. D, YODER, S. L, GAGE, J. W, ROLAND, G. E

“…Bactericidal activities of clinafloxacin, CI-990 and ciprofloxacin were examined and compared for a small collection of gram-positive and gram-negative…”
Get full text

Efficacy of quinolones in preventing Staphylococcus aureus-induced abscess in mice by Cohen, M A, Gage, J W, Huband, M D, Meservey, M A, VanderRoest, S R, Yoder, S L

“…The new fluoroquinolones clinafloxacin, CI-990 (PD 131112/PD 131628), sparfloxacin, and PD 138312 were bactericidal against Staphylococcus aureus with MICs >…”
Get more information

In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models by Cohen, M A, Wold, S A, Meservey, M A, Gage, J W, Heifetz, C L, Mailloux, G B, Roland, G E, Yoder, S L

“…Cefdinir (FK482), a new oral cephalosporin, displayed potent oral activity versus induced infections in mice. In studies using beta-lactamase-nonproducing…”
Get more information

Comparative Antibiotic Activity Versus Vancomycin Intermediate-Susceptible Staphylococcus aureus by Huband, MD, Cohen, MA, Gage, JW, VanderRoest, SR

Get full text

Sources of Unidentified Growth Factors for Baby Pigs by Gage, J. W., Jr, Wilbur, R. D, Hays, V. W, Speer, V. C, Catron, D. V

Get full text

3-Aminoquinazolinediones as a New Class of Antibacterial Agents Demonstrating Excellent Antibacterial Activity Against Wild-Type and Multidrug Resistant Organisms by Ellsworth, EL, Tran, T P, Showalter, HDH, Sanchez, J P, Watson, B M, Stier, MA, Domagala, J M, Gracheck, S J, Joannides, E T, Shapiro, MA, Dunham, SA, Hanna, D L, Huband, MD, Gage, J W

“…The 3-aminoquinzolinediones represent a new series of antibacterial agents structurally related to the fluoroquinolones. They are inhibitors of bacterial…”
Get full text